Axcelis Technologies (NASDAQ: ACLS) reported Q1 EPS of $0.48, $0.16 better than the analyst estimate of $0.32. Revenue for the quarter came in at $132.8 million versus the consensus estimate of $126.43 million.

President and CEO Mary Puma commented, \"Axcelis delivered strong first quarter financial performance, driven by the growing demand for our Purion™ products and strength across a number of markets. Given market trends and the traction of our Purion base products and product line extensions, Axcelis is on track to exceed $550 million in revenue for the full year 2021, achieving this goal a full year ahead of schedule.\"

GUIDANCE:

Axcelis Technologies sees Q2 2021 EPS of $0.43-$0.47, versus the consensus of $0.43. Axcelis Technologies sees Q2 2021 revenue of $135-140 million, versus the consensus of $132.05 million.

For earnings history and earnings-related data on Axcelis Technologies (ACLS) click here.